{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:46:25Z","timestamp":1792255585153,"version":"4.4.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Barrett\u2019s esophagus (BE) is the only recognized precursor to esophageal adenocarcinoma (EAC). Endoscopic monitoring of BE allows for early detection and prevention against advanced cancer, which carries high morbidity and mortality. Over the past two decades, management of early EAC has shifted from esophagectomy toward organ-preserving endoscopic eradication therapy (EET), including endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and ablative modalities such as radiofrequency ablation, cryotherapy, and hybrid argon plasma coagulation. EMR remains standard for most lesions with pre-invasive neoplasia and small intramucosal EAC, while ESD provides technical advantages for larger or complex neoplasia, though comparative long-term outcome data are limited. Ablation after resection achieves durable clearance of dysplasia and intestinal metaplasia, with emerging therapies showing promise in refractory or high-risk cases. Structured post-EET surveillance is critical, as recurrence risk is highest within 1\u20132\u00a0years of achieving remission, but persists at lower levels long-term. The risk of recurrence is influenced by lesion characteristics, treatment strategy, and center experience. Personalized, risk-adapted surveillance is increasingly supported, incorporating clinical factors such as BE length, baseline histology and prior treatment. More recently, molecular biomarkers and artificial intelligence (AI)-driven integration of clinical and genomic features have shown promising results. Future research should optimize tissue acquisition, refine biomarker panels, and validate AI-enabled predictive models to improve patient selection, minimize recurrence, and guide cost-effective, individualized care.<\/jats:p>","DOI":"10.1093\/dote\/doag112","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:03:38Z","timestamp":1790769818000},"source":"Crossref","is-referenced-by-count":0,"title":["Endoscopic eradication therapy of Barrett\u2019s dysplasia and early adenocarcinoma: where we stand and what\u2019s next"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-7286","authenticated-orcid":false,"given":"Vijayvardhan","family":"Kamalumpundi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic , 200 First Street SW, Rochester, MN 55905,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6520-443X","authenticated-orcid":false,"given":"Andreas V","family":"Hadjinicolaou","sequence":"additional","affiliation":[{"name":"Early Cancer Institute , University of Cambridge, Adrian Way, Cambridge Biomedical Campus, Cambridge CB20XZ, United Kingdom; Department of Digestive Diseases, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ ,","place":["United Kingdom"]},{"name":"Department of Gastroenterology, Digestive Diseases, Cambridge University Hospital NHS Foundation Trust , Addenbrooke's Hospital, Hills Road, Cambridge CB20QQ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4866-7026","authenticated-orcid":false,"given":"Massimiliano","family":"Di Pietro","sequence":"additional","affiliation":[{"name":"Early Cancer Institute , University of Cambridge, Adrian Way, Cambridge Biomedical Campus, Cambridge CB20XZ, United Kingdom; Department of Digestive Diseases, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0495-3795","authenticated-orcid":false,"given":"Cadman L","family":"Leggett","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , 200 First Street SW, Rochester, MN 55905,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"issue":"6","key":"2026101712301736200_ref1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2025.03.021","article-title":"Barrett\u2019s Oesophagus surveillance versus endoscopy at need study (BOSS): a randomized controlled trial","volume":"169","author":"Old","year":"2025","journal-title":"Gastroenterology"},{"issue":"5","key":"2026101712301736200_ref2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/gutjnl-2014-307278","article-title":"Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel","volume":"64","author":"Duits","year":"2015","journal-title":"Gut"},{"issue":"6","key":"2026101712301736200_ref3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1053\/j.gastro.2025.09.012","article-title":"AGA clinical practice guideline on surveillance of Barrett\u2019s esophagus","volume":"169","author":"Wani","year":"2025","journal-title":"Gastroenterology"},{"issue":"3","key":"2026101712301736200_ref4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1053\/j.gastro.2019.09.051","article-title":"AGA clinical practice update on endoscopic treatment of Barrett\u2019s esophagus with dysplasia and\/or early cancer: expert review","volume":"158","author":"Sharma","year":"2020","journal-title":"Gastroenterology"},{"issue":"22","key":"2026101712301736200_ref5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","article-title":"Radiofrequency ablation in Barrett's esophagus with dysplasia","volume":"360","author":"Shaheen","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"2026101712301736200_ref6","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"2026101712301736200_ref7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1053\/j.gastro.2024.03.019","article-title":"AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett\u2019s Esophagus and Related Neoplasia","volume":"166","author":"Rubenstein","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"2026101712301736200_ref8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.14309\/ajg.0000000000001680","article-title":"Diagnosis and Management of Barrett's esophagus: an updated ACG guideline","volume":"117","author":"Shaheen","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"2026101712301736200_ref9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1055\/a-2176-2440","article-title":"Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) guideline","volume":"55","author":"Weusten","year":"2023","journal-title":"Endoscopy"},{"issue":"6","key":"2026101712301736200_ref10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/gutjnl-2023-331557","article-title":"National Institute for health and care excellence (NICE) guidance on monitoring and management of Barrett\u2019s oesophagus and stage I oesophageal adenocarcinoma","volume":"73","author":"Pietro","year":"2024","journal-title":"Gut"},{"issue":"5","key":"2026101712301736200_ref11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.gie.2018.11.035","article-title":"Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett\u2019s esophagus increases the risk of dysplasia recurrence: meta-analysis","volume":"89","author":"Sawas","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"2026101712301736200_ref12","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s10620-020-06377-1","article-title":"Long-term quality of life following endoscopic therapy compared to esophagectomy for neoplastic Barrett's esophagus","volume":"66","author":"Reddy","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"3","key":"2026101712301736200_ref13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/j.gastro.2013.11.006","article-title":"Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus","volume":"146","author":"Pech","year":"2014","journal-title":"Gastroenterology"},{"issue":"12","key":"2026101712301736200_ref14","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1055\/s-0030-1255858","article-title":"Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens","volume":"42","author":"Alvarez Herrero","year":"2010","journal-title":"Endoscopy"},{"issue":"9","key":"2026101712301736200_ref15","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/ueg2.70140","article-title":"Cancer burden on piecemeal endoscopic resection of Early adenocarcinoma in Barrett's Oesophagus correlates with the risk of neoplastic recurrence","volume":"13","author":"Hattersley","year":"2025","journal-title":"United European Gastroenterol J"},{"issue":"12","key":"2026101712301736200_ref16","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.cgh.2014.04.010","article-title":"Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia","volume":"12","author":"Konda","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2026101712301736200_ref17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cgh.2020.11.017","article-title":"Comparative outcomes of cap assisted endoscopic resection and endoscopic submucosal dissection in dysplastic Barrett's esophagus","volume":"20","author":"Codipilly","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2026101712301736200_ref18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/apt.13254","article-title":"Systematic review: the prevention of oesophageal stricture after endoscopic resection","volume":"42","author":"Barret","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2026101712301736200_ref19","doi-asserted-by":"publisher","DOI":"10.1055\/a-2637-1928","article-title":"Hyperbaric oxygen and steroids for preventing stricture after large esophageal endoscopic submucosal dissection","volume":"13","author":"Zeng","year":"2025","journal-title":"Endosc Int Open"},{"issue":"6","key":"2026101712301736200_ref20","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1007\/s00464-025-11718-0","article-title":"Esophageal mucosal auto-transplantation versus acellular dermal matrix transplantation for preventing esophageal stenosis after endoscopic resection in patients with superficial esophageal mucosal lesions","volume":"39","author":"Mou","year":"2025","journal-title":"Surg Endosc"},{"issue":"3","key":"2026101712301736200_ref21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.gie.2024.08.011","article-title":"Prophylactic endoscopic vacuum therapy for stricture prevention after wide-field endoscopic submucosal dissection of superficial esophageal cancer","volume":"101","author":"Blasberg","year":"2025","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"2026101712301736200_ref22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/gutjnl-2015-310126","article-title":"A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett\u2019s neoplasia","volume":"66","author":"Terheggen","year":"2017","journal-title":"Gut"},{"issue":"5","key":"2026101712301736200_ref23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.gie.2024.06.012","article-title":"Comparison of EMR versus endoscopic submucosal dissection for Barrett's neoplasia and esophageal adenocarcinoma: a systematic review and meta-analysis","volume":"100","author":"Fujiyoshi","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"2026101712301736200_ref24","doi-asserted-by":"publisher","DOI":"10.1055\/a-2422-2815","article-title":"Journey to complete remission of dysplasia and intestinal metaplasia after ESD and EMR of Barrett's esophagus-related neoplasia","volume":"13","author":"Joseph","year":"2025","journal-title":"Endosc Int Open"},{"issue":"3","key":"2026101712301736200_ref25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1053\/j.gastro.2017.05.044","article-title":"Late recurrence of Barrett\u2019s esophagus after complete eradication of intestinal metaplasia is rare: final report from ablation in intestinal metaplasia containing dysplasia trial","volume":"153","author":"Cotton","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"2026101712301736200_ref26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/gutjnl-2015-309298","article-title":"Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)","volume":"65","author":"Phoa","year":"2016","journal-title":"Gut"},{"issue":"3","key":"2026101712301736200_ref27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.gie.2020.03.3756","article-title":"Radiofrequency ablation for low-grade dysplasia in Barrett\u2019s esophagus: long-term outcome of a randomized trial","volume":"92","author":"Pouw","year":"2020","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"2026101712301736200_ref28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2020-322082","article-title":"Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial","volume":"70","author":"Barret","year":"2021","journal-title":"Gut"},{"issue":"2","key":"2026101712301736200_ref29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.gie.2022.02.016","article-title":"Endoscopic eradication therapy for Barrett\u2019s esophagus\u2013related neoplasia: a final 10-year report from the UK national HALO radiofrequency ablation registry","volume":"96","author":"Wolfson","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"07","key":"2026101712301736200_ref30","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1055\/s-0032-1326423","article-title":"Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett\u2019s esophagus with early neoplasia: a prospective multicenter study","volume":"45","author":"Van Vilsteren","year":"2013","journal-title":"Endoscopy"},{"issue":"4","key":"2026101712301736200_ref31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/PAS.0000000000000566","article-title":"Predictors of treatment failure after radiofrequency ablation for intramucosal adenocarcinoma in Barrett esophagus: a multi-institutional retrospective cohort study","volume":"40","author":"Agoston","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2026101712301736200_ref32","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003752","article-title":"Spray cryotherapy esophageal consortium consensus recommendations for liquid nitrogen spray cryotherapy in Barrett's esophagus and esophageal Cancer using a modified Delphi process","author":"Shah","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2026101712301736200_ref33","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1007\/s10620-021-06991-7","article-title":"Outcomes of radiofrequency ablation compared to liquid nitrogen spray cryotherapy for the eradication of dysplasia in Barrett's esophagus","volume":"67","author":"Fasullo","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"2","key":"2026101712301736200_ref34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.gie.2024.01.023","article-title":"Liquid nitrogen spray cryotherapy for eradication of dysplastic Barrett's esophagus: results from a multicenter prospective registry","volume":"100","author":"Eluri","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"2026101712301736200_ref35","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.gie.2018.02.021","article-title":"Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis","volume":"87","author":"Visrodia","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"2026101712301736200_ref36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.tige.2020.07.004","article-title":"Cryoballoon and Cryospray ablation therapies are equivalent for eradication of Barrett's esophagus","volume":"23","author":"Alshelleh","year":"2021","journal-title":"Techniques and Innovations in Gastrointestinal Endoscopy"},{"issue":"3","key":"2026101712301736200_ref37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/dote.12330","article-title":"Safety and efficacy of endoscopic spray cryotherapy for Barrett's dysplasia: results of the National Cryospray Registry","volume":"29","author":"Ghorbani","year":"2016","journal-title":"Dis Esophagus"},{"issue":"2","key":"2026101712301736200_ref38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.gie.2024.01.023","article-title":"Liquid nitrogen spray cryotherapy for eradication of dysplastic Barrett\u2019s esophagus: results from a multicenter prospective registry","volume":"100","author":"Eluri","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"2026101712301736200_ref39","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1007\/s00464-023-10313-5","article-title":"Radiofrequency ablation versus hybrid argon plasma coagulation in Barrett's esophagus: a prospective randomised trial","volume":"37","author":"Knabe","year":"2023","journal-title":"Surg Endosc"},{"issue":"4","key":"2026101712301736200_ref40","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/s00464-015-4336-1","article-title":"Efficacy and safety of hybrid-APC for the ablation of Barrett\u2019s esophagus","volume":"30","author":"Manner","year":"2016","journal-title":"Surg Endosc"},{"issue":"7","key":"2026101712301736200_ref41","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/ajg.2017.166","article-title":"Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (treatment with resection and endoscopic ablation techniques for Barrett's esophagus) consortium","volume":"112","author":"Wani","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"2026101712301736200_ref42","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1007\/s10620-023-07968-4","article-title":"High proportions of newly detected visible lesions and pathology grade change among patients with Barrett's esophagus referred to expert centers","volume":"68","author":"Davis","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"8","key":"2026101712301736200_ref43","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gutjnl-2014-308501","article-title":"Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry","volume":"64","author":"Haidry","year":"2015","journal-title":"Gut"},{"issue":"4","key":"2026101712301736200_ref44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/flgastro-2019-101247","article-title":"Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia","volume":"11","author":"Alzoubaidi","year":"2020","journal-title":"Frontline Gastroenterol"},{"issue":"10","key":"2026101712301736200_ref45","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1055\/a-0996-0912","article-title":"Curriculum for endoscopic submucosal dissection training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) position statement","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"issue":"3","key":"2026101712301736200_ref46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.gie.2016.09.022","article-title":"Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis","volume":"85","author":"Desai","year":"2017","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"2026101712301736200_ref47","doi-asserted-by":"publisher","first-page":"E430","DOI":"10.1055\/s-0043-106578","article-title":"Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis","volume":"5","author":"Fujii-Lau","year":"2017","journal-title":"Endosc Int Open"},{"issue":"5","key":"2026101712301736200_ref48","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.gie.2018.11.035","article-title":"Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis","volume":"89","author":"Sawas","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"2026101712301736200_ref49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/gutjnl-2020-322615","article-title":"Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation \u00b1 endoscopic resection: results from the national Dutch database in a 10-year period","volume":"71","author":"Munster","year":"2022","journal-title":"Gut"},{"issue":"11","key":"2026101712301736200_ref50","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.cgh.2020.01.019","article-title":"Recurrence is rare following complete eradication of intestinal metaplasia in patients with Barrett's esophagus and peaks at 18 months","volume":"18","author":"Wani","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2026101712301736200_ref51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.gie.2014.01.007","article-title":"Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett's esophagus","volume":"80","author":"Fudman","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"2026101712301736200_ref52","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.gie.2025.01.026","article-title":"Long-term outcomes after endoscopic eradication therapy for dysplastic and T1a adenocarcinoma-related Barrett's esophagus: higher rate of late dysplastic recurrence with radiofrequency ablation monotherapy","volume":"102","author":"He","year":"2025","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"2026101712301736200_ref53","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1136\/gutjnl-2018-317513","article-title":"Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study","volume":"68","author":"Sami","year":"2019","journal-title":"Gut"},{"issue":"6","key":"2026101712301736200_ref54","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.gie.2020.10.027","article-title":"Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus","volume":"93","author":"Solfisburg","year":"2021","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"2026101712301736200_ref55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1053\/j.gastro.2022.03.020","article-title":"Dysplastic recurrence after successful treatment for Early Barrett's neoplasia: development and validation of a prediction model","volume":"163","author":"Munster","year":"2022","journal-title":"Gastroenterology"},{"issue":"2","key":"2026101712301736200_ref56","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1053\/j.gastro.2021.10.038","article-title":"Abnormal TP53 predicts risk of progression in patients with Barrett's esophagus regardless of a diagnosis of dysplasia","volume":"162","author":"Redston","year":"2022","journal-title":"Gastroenterology"},{"issue":"12","key":"2026101712301736200_ref57","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1055\/a-2642-7584","article-title":"Evaluation of an improved computer-aided detection system for Barrett's neoplasia in real-world imaging conditions","volume":"57","author":"Jong","year":"2025","journal-title":"Endoscopy"},{"issue":"9","key":"2026101712301736200_ref58","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1055\/a-2296-5696","article-title":"Influence of artificial intelligence on the diagnostic performance of endoscopists in the assessment of Barrett's esophagus: a tandem randomized and video trial","volume":"56","author":"Meinikheim","year":"2024","journal-title":"Endoscopy"},{"issue":"2","key":"2026101712301736200_ref59","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.gie.2019.09.016","article-title":"Comparing blind spots of unsedated ultrafine, sedated, and unsedated conventional gastroscopy with and without artificial intelligence: a prospective, single-blind, 3-parallel-group, randomized, single-center trial","volume":"91","author":"Chen","year":"2020","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"2026101712301736200_ref60","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1055\/a-2537-3510","article-title":"The development and ex vivo evaluation of a computer-aided quality control system for Barrett's esophagus endoscopy","volume":"57","author":"Jong","year":"2025","journal-title":"Endoscopy"},{"issue":"7","key":"2026101712301736200_ref61","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1055\/a-2534-1164","article-title":"Use of artificial intelligence in submucosal vessel detection during third-space endoscopy","volume":"57","author":"Scheppach","year":"2025","journal-title":"Endoscopy"},{"issue":"10500","key":"2026101712301736200_ref62","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0140-6736(25)01021-9","article-title":"Biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus: prospective evaluation of UK real-world implementation","volume":"406","author":"Tan","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"2026101712301736200_ref63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1158\/1940-6207.Capr-25-0215","article-title":"Discovery and validation of molecular biomarkers for differentiation of nondysplastic Barrett's esophagus from high-grade dysplasia and esophageal adenocarcinoma","volume":"19","author":"Matchett","year":"2026","journal-title":"Cancer Prev Res (Phila)"},{"issue":"11","key":"2026101712301736200_ref64","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.14309\/ajg.0000000000002850","article-title":"Multicenter, prospective trial of nonendoscopic biomarker-driven detection of Barrett's esophagus and esophageal adenocarcinoma","volume":"119","author":"Moinova","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"2026101712301736200_ref65","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ueg2.12114","article-title":"Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression","volume":"9","author":"Klaver","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"2026101712301736200_ref66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/mcg.0000000000002255","article-title":"The tissue systems pathology test predicts risk of progression in patients with Barrett's esophagus: systematic review and Meta-analysis","volume":"60","author":"Houghton","year":"2025","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"2026101712301736200_ref67","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41591-020-1033-y","article-title":"Genomic copy number predicts esophageal cancer years before transformation","volume":"26","author":"Killcoyne","year":"2020","journal-title":"Nat Med"},{"issue":"2","key":"2026101712301736200_ref68","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/gutjnl-2024-333364","article-title":"Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study","volume":"74","author":"Miyoshi","year":"2025","journal-title":"Gut"},{"issue":"1","key":"2026101712301736200_ref69","doi-asserted-by":"publisher","first-page":"2604334","DOI":"10.1080\/19490976.2025.2604334","article-title":"A machine-learning informed circulating microbial DNA signature for early diagnosis of esophageal adenocarcinoma","volume":"18","author":"Li","year":"2026","journal-title":"Gut Microbes"},{"issue":"05","key":"2026101712301736200_ref70","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1055\/a-1541-7659","article-title":"Endoscopic submucosal dissection vs. endoscopic mucosal resection for early Barrett's neoplasia in the west: a retrospective study","volume":"54","author":"Perez","year":"2022","journal-title":"Endoscopy."},{"key":"2026101712301736200_ref71","doi-asserted-by":"publisher","DOI":"10.1055\/a-2531-8227","article-title":"Efficacy and safety of H-APC in Barrett's esophagus: Italian prospective multicenter study","volume":"13","author":"Massimi","year":"2025","journal-title":"Endosc Int Open"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/39\/5\/doag112\/72066779\/doag112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/39\/5\/doag112\/72066779\/doag112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:30:27Z","timestamp":1792254627000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doag112\/8935295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doag112","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,2]]},"article-number":"doag112"}}